Genome Editing and Dialogic Responsibility: “What's in a Name?”.

The article focuses on the challenges in finding a suitable expression in French to refer to CRISPR-Cas9, referencing the article ""Editing" genes: A case study about how language matters in bioethics" by M. O'Keefe and colleagues within the issue. Topics mentioned include how adopting the English wording would oppose a national language being a civic asset, the principle of dialogic responsibility, and the use of the expression targeted genome engineering to refer to CRISPR-Cas9 in general.